Topical axitinib is a potent inhibitor of corneal neovascularization
Clinical&Experimental Ophthalmology,Volume 0, Issue ja, -Not available-.
Source: Clinical and Experimental Ophthalmology - Category: Opthalmology Authors: Mariola
LLed ó Riquelme
MD
,
Ezequiel
Campos‐Mollo
PhD
,
Laura
Fernández‐Sánchez
PhD Source Type: research
More News: Opthalmology